Pfizer Global Medical Grants Addressing Knowledge Gaps in Aplastic Anemia RFP

Well-being, Health and Biomedical Discovery

Deadlines

Academic Unit: inquire with unit

Memorial Deadline: Monday 17th, June 2024

External Deadline: Tuesday 25th, June 2024


Description

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

 

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Date RFP Issued: May 7, 2024

Geographic Scope: Global (excluding the United States)

Clinical Area: Aplastic Anemia

Link to full RFP: Addressing Knowledge Gaps in Aplastic Anemia

Application Due Date: June 25, 2024

Specific Area of Interest: Projects that will be considered for Pfizer support will focus on improving the care of patients by addressing knowledge gaps in the following areas:

  • – early identification and diagnosis of aplastic anemia (AA) patients
  • – awareness of AA, in order to ensure appropriate transition of patients to specialty clinical centers of excellence for care
  • – current standards for the treatment of AA and its complications
  • – clinical management of special patient subpopulations (i.e. Pediatrics or Elderly) and challenging cases of AA patients

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Amanda Stein, Grant Officer (amanda.j.stein@pfizer.com).


Funding Sources

Pfizer Inc



This opportunity was posted by: RGCS

Last modified: May 7, 2024